The 20 Best Pseudomyxoma Peritonei Doctors near Livingston, NJ

"Dr. Angela Alistar is a board-certified medical oncologist with Atlantic Hematology Oncology, Atlantic Medical Group. Dr. Alistar is Medical Director of GI Medical Oncology at Morristown Medical Center where she is also Medical Director of the phase 1 Breakthrough Treatment Center. Her research focus is related to immuno-oncology and cancer metabolism in gastrointestinal cancer such as: pancreatic tumors, cholangiocarcinoma, colorectal, esophageal, gastric cancer and hepatocellular carcinoma. Her clinical research projects involve active collaborative efforts with other medical departments, such as radiation oncology and surgical oncology, as well as genomics and cancer biology.Recently, she published in Lancet Oncology the results of a Phase I clinical study in pancreatic cancer that are very promising for advancing the field for this disease. This study has shown impressive synergy of a novel agent, CPI -613 in combination with chemotherapy. She is co-leading the national multi-site, randomized study of this promising combination, as well as many other phase 1-3 clinical trials.Dr. Alistar comes to Atlantic Health System from Wake Forest School of Medicine where she had a heavy emphasis on clinical trials and clinical research. At Wake Forest, she led the GI oncology disease oriented team as a gastrointestinal medical oncology physician and researcher, bringing cutting-edge treatments to patients. She designed, secured funding for and conducted five investigator-initiated therapeutic clinical trials, with four of them being phase one. Her work involved maintenance of a sponsor-investigator investigational new drug. She is passionate about Precision Oncology and Immunotherapies and seeks to identify novel treatment strategies for her patients.Past positions at Wake Forest include being a member of the Translational Cancer Genomics Committee, the GI Tumor Board, Internal Medicine Grand Rounds, and the Hepatobiliary Oncology Committee. She is a member of several health care organizations, such as the American Society of Clinical Oncology, the American Society of Hospice and Palliative Care Medicine, and the American Society of Hematology, among many others. As well, she is a member and advisor for several other health care institutions. She was recently awarded the ""Danny Danielson Translational Innovation Award"" by Hoosier Cancer Research Network for her commitment to clinical research. Dr. Alistar received her medical degree from University of Medicine and Pharmacy, Cluj Napoca, Romania and her residency at Englewood Hospital and Medical Center, NJ, where she was chief resident. After her residency, she completed hematology oncology fellowship at Mount Sinai School of Medicine, Tisch Cancer Institute. She is affiliated with Atlantic Medical Group, and is a participating provider of Atlantic Accountable Care Organization, and sees patients at Morristown Medical Center.". Dr. Alistar is rated as a Distinguished provider by MediFind in the treatment of Pseudomyxoma Peritonei. Her top areas of expertise are Pancreatic Cancer, Familial Pancreatic Cancer, Colorectal Cancer, and Stomach Cancer.

Thad Denehy is an Oncologist in West Orange, New Jersey. Dr. Denehy is rated as an Advanced provider by MediFind in the treatment of Pseudomyxoma Peritonei. His top areas of expertise are Vulvar Cancer, Ovarian Carcinosarcoma, Virilizing Ovarian Tumor, Hysterectomy, and Oophorectomy. Dr. Denehy is currently accepting new patients.

Vivek Maheshwari is a General Surgeon and a Surgical Oncologist in West Orange, New Jersey. Dr. Maheshwari is rated as an Experienced provider by MediFind in the treatment of Pseudomyxoma Peritonei. His top areas of expertise are Hernia, Gallstones, Choledocholithiasis, Colostomy, and Hernia Surgery. Dr. Maheshwari is currently accepting new patients.

Joshua A. Strauss, MD, is a hematologist-oncologist with Advanced Care Oncology and Hematology Associates (ACOHA), part of the Atlantic Medical Group (AMG). He is fellowship-trained and double-board-certified in medical oncology and hematology by the American Board of Internal Medicine. He has more than 15 years of experience taking care of patients with a variety of malignancies and blood disorders. Dr. Strauss especially takes pride in treating his patients with compassion and going the extra mile to deliver the highest quality of care.Dr. Strauss strives to incorporate the most up-to-date knowledge in the field with an approach geared to the needs of each individual patient. He maintains clinical interests in gastrointestinal, urologic and gynecologic cancers, as well as leukemia, lymphoma and benign blood disorders. Dr. Strauss joined ACOHA in 2015.After earning his medical degree at the Albert Einstein College of Medicine in the Bronx, where he graduated with special distinction for research in medical oncology, Dr. Strauss completed his residency in internal medicine at New York University Langone Medical Center. He then completed fellowship training in hematology/oncology at New York-Presbyterian/Columbia University Medical Center, also in NYC, where he participated in high-level research and published several peer-reviewed articles in gastrointestinal cancer.Dr. Strauss has been voted by physician colleagues as a “Top Doctor” in New Jersey Monthly magazine every year since 2020. He is a member of the American Society of Clinical Oncology and the American Society of Hematology, and is a participating provider of the Atlantic Accountable Care Organization. Dr. Strauss is rated as an Experienced provider by MediFind in the treatment of Pseudomyxoma Peritonei. His top areas of expertise are Childhood Iron Deficiency Anemia, Iron Deficiency Anemia, Myelodysplastic Syndrome (MDS), Colorectal Cancer, and Bone Marrow Aspiration.

Matthew Stuart, MD, is a fellowship-trained hematologist/oncologist with Advanced Care Oncology and Hematology (ACOHA), part of Atlantic Medical Group (AMG). Dr. Stuart’s clinical interests include colorectal, pancreatic, gastrointestinal, lung, urological (GU) cancer, hematology, anemia, clotting disorders, lymphoma, multiple myeloma, and preventative care.Board-certified in internal medicine, medical oncology and hematology by the American Board of Internal Medicine, Dr. Stuart believes in treating the patient as a whole, implementing evidence-based, patient-centered, and cost-conscious care. His recent research includes evaluating race-based differences in treatment complications in patients with metastatic prostate cancer, improving vaccination rates in patients receiving chemotherapy, and providing community outreach to increase lung cancer screening and early detection.Dr. Stuart earned his medical degree at Rutgers New Jersey Medical School, Newark, NJ, where he served as director of the Student Family Health Care Center, the mini-medical school and premedical honors program, and the Institute for Public Understanding of Medicine in Action. He performed his internal medicine residency at Montefiore Medical Center, Bronx, NY, where he served on the Emergency-Internal Medicine and Resident Recruitment committees and received the Leo M. Davidoff Society Award for outstanding achievement in the teaching of medical students and a program innovation and improvement award. He remained at Montefiore to complete a fellowship in hematology/oncology, where he was named the chief hematology fellow and served on the Program Evaluation Committee. Following his fellowship training, he joined ACOHA in 2020.Fluent in conversational Spanish, Dr Stuart has presented at national and international medical conferences. He is a participating provider of the Atlantic Accountable Care Organization. Dr. Stuart is rated as an Experienced provider by MediFind in the treatment of Pseudomyxoma Peritonei. His top areas of expertise are Childhood Iron Deficiency Anemia, Familial Colorectal Cancer, Colorectal Cancer, Iron Deficiency Anemia, and Bone Marrow Aspiration.

Usman Shah is a Hematologist and an Oncologist in Summit, New Jersey. Dr. Shah is rated as an Advanced provider by MediFind in the treatment of Pseudomyxoma Peritonei. His top areas of expertise are Familial Colorectal Cancer, Colorectal Cancer, Familial Pancreatic Cancer, Non-Hodgkin Lymphoma, and Bone Marrow Aspiration. Dr. Shah is currently accepting new patients.

Lee Starker, MD, PhD, is a medical director of surgical oncology for the eastern region with a special interest in thyroid and parathyroid tumors and cancers, endocrine disorders, melanoma, hormones and metabolism, and cancer genetics. He is highly trained in pancreatic and complex hepatobiliary surgery. He also specializes in NanoKnife® to treat unresectable pancreatic and liver cancers as well as hyperthermic intraperitoneal chemotherapy (HIPEC), which is a highly concentrated, heated chemotherapy treatment delivered directly to the abdomen during surgery for peritoneal malignancies.After completing his surgical residency at Yale New Haven Hospital in Connecticut and surgical oncology fellowship training at MD Anderson Cancer Center in Texas, Dr. Starker returned to his New Jersey roots. Prior to that, he earned a PhD in epigenetics and genetics of parathyroid tumors from Uppsala University in Sweden, where he was chief resident and fellow. While studying there, he received the Gold Humanism Award, which recognizes excellence in clinical care, leadership, compassion and dedication to service. He has also been named an NJ Top Doctor annually by NJ Monthly Magazine.Dr. Starker is widely published in various medical journals, including the World Journal of Oncology and International Journal of Endocrinology. He is a member of the Society of Surgical Oncology. Dr. Starker and his partners provide patients with the latest surgical innovations and clinical research options. He is a participating provider of the Atlantic Accountable Care Organization. Dr. Starker is rated as an Advanced provider by MediFind in the treatment of Pseudomyxoma Peritonei. His top areas of expertise are Familial Pancreatic Cancer, Colorectal Cancer, Familial Colorectal Cancer, Small Bowel Resection, and Pancreatectomy.

Lawrence Harrison, MD, is chief of Atlantic Surgical Oncology, which provides expert care across a broad spectrum of cancers, focusing on hepatobiliary, pancreatic, colorectal, gastroesophageal, skin and soft tissue cancers. As fellowship-trained surgical oncologists, Dr. Harrison and his partners provide patients with the latest in surgical innovations and clinical research options. Atlantic Surgical Oncology works closely with medical oncology, radiation oncology and other specialists in a multidisciplinary fashion on two campuses of the Carol G. Simon Cancer Center at Morristown Medical Center and at Overlook Medical Center in Summit. Dr. Harrison has been a surgical innovator since finishing fellowship training at Memorial Sloan Kettering Cancer Center in New York City. He has extensive training in novel surgical techniques, including in hyperthermic intraperitoneal chemotherapy (HIPEC), which is a highly concentrated, heated chemotherapy treatment delivered directly to the abdomen during surgery. Prior to joining Atlantic Surgical Oncology, Dr. Harrison served as director of surgical oncology at Valley Hospital in Ridgewood where he developed expertise in robotic surgery, performing more than 200 complex robotic surgical procedures. He also was director of the Advanced Gastrointestinal Surgical Fellowship. Previously, Dr. Harrison was associate professor of surgery and chief of the Division of Surgical Oncology at University Hospital in Newark for 12 years. In addition to his clinical practice, he was involved in research and taught medical residents and students. He is a fellow of the American College of Surgeons. Dr. Harrison sees patients at Morristown and Overlook medicals centers, and provides consultative services to Newton, Chilton and Hackettstown medical centers. Dr. Harrison is rated as an Advanced provider by MediFind in the treatment of Pseudomyxoma Peritonei. His top areas of expertise are Familial Colorectal Cancer, Colorectal Cancer, Pancreatic Cancer, Pancreatectomy, and Small Bowel Resection.

Jennifer Wagmiller is an Oncologist in Livingston, New Jersey. Dr. Wagmiller is rated as an Advanced provider by MediFind in the treatment of Pseudomyxoma Peritonei. Her top areas of expertise are Ovarian Carcinosarcoma, Virilizing Ovarian Tumor, Breast Cancer, and Paget Disease of the Breast. Dr. Wagmiller is currently accepting new patients.

Dr. Saksena is a dynamic, clinically oriented, hematologist/oncologist with several years of experience in the treatment of various cancers and blood disorders. She is triple board-certified in internal medicine, medical oncology, and hematology by the American Board of Internal Medicine. Her strong medical back- ground combined with her passion to build meaningful patient-centered relationships enables her to deliver leading-edge care in a highly personalized manner. She practices comprehensive cancer care, with direct access to the latest clinical trials, and works closely with surgeons, radiation oncologists, genetic counselors, nurses, social workers and dietitians.Dr. Saksena attended Lehigh University, where she obtained a bachelor of science degree in behavioral neuroscience. She earned her medical degree at Jefferson Medical College, part of Thomas Jefferson University in Philadelphia, and then completed her hematology/oncology fellowship at Rutgers Cancer Institute of New Jersey (CINJ) & Robert Wood Johnson University Hospital in New Brunswick.During her education, Dr. Saksena received a number of honors, awards and scholarships for her clinical work, leadership roles, and research. She served as chief fellow of hematology oncology while at Rutgers CINJ, the state’s only National Cancer Institue-designated cancer center. Dr. Saksena also speaks Hindi, Gujarati and conversational Spanish, and is committed to community outreach through advocacy groups and as a liaison of the American Medical Women’s Association.Dr. Saksena is a member of Atlantic Medical Group, and is a participating provider in the Atlantic Accountable Care Organization. Dr. Saksena is rated as an Experienced provider by MediFind in the treatment of Pseudomyxoma Peritonei. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Familial Colorectal Cancer, and Posterior Fossa Tumor.

Stephen Abo is an Oncologist in Belleville, New Jersey. Dr. Abo is rated as a Distinguished provider by MediFind in the treatment of Pseudomyxoma Peritonei. His top areas of expertise are Shwartzman Phenomenon, Venous Thromboembolism (VTE), Inflammatory Breast Cancer, and Angiosarcoma.

Nana Tchabo, MD, FACOG Dr. Nana Tchabo is dual board certified in gynecology-oncology and obstetrics and gynecology, with fellowship training in minimally invasive gynecologic surgery and robotic procedures. A native of Baltimore, MD, Dr. Tchabo is a gynecologic oncologist at Atlantic Health System’s Morristown and Overlook Medical Centers Women’s Cancer Center, part of the Atlantic Medical Group. After graduating from Brown University in 1996 with a bachelor’s degree in neuroscience and a minor in women’s health, Dr. Tchabo attended Brown University School of Medicine for her medical degree, where she was cited for academic excellence. Dr. Tchabo completed her residency in obstetrics and gynecology at Georgetown University in 2004 and pursued additional research training at the National Cancer Institute of the National Institutes of Health in Bethesda, MD, and gynecologic oncology fellowship training at Roswell Park Cancer Institute in Buffalo, NY. Committed to cancer prevention and survivorship, Dr. Tchabo is a principal investigator on many of the gynecologic cancer clinical research trials available at the Carol G. Simon Cancer Center. She also serves as associate residency director for Gynecology at Overlook Medical Center. Dr. Tchabo is an assistant clinical professor at the Sidney Kimmel Medical College of Thomas Jefferson University and is a former assistant clinical professor at Mount Sinai School of Medicine’s department of Obstetrics, Gynecology and Reproductive Science. Dr. Tchabo is rated as an Experienced provider by MediFind in the treatment of Pseudomyxoma Peritonei. Her top areas of expertise are Endometrial Cancer, Ovarian Carcinosarcoma, Malignant Mixed Mullerian Tumor, Hysterectomy, and Oophorectomy.

Dr. Kai Bickenbach provides cancer patients with exceptional surgical care at Atlantic Surgical Oncology. His areas of specialty include melanoma, sarcoma, pancreatic cancer, liver and biliary cancer, esophageal and gastric cancer and colorectal cancer. He is trained in the use of many novel therapies, including the NanoKnife® to treat un-resectable pancreatic and liver tumors, as well as hepatic arterial infusion pumps. Dr. Bickenbach and his partners are fellowship trained surgical oncologists providing patients the latest in surgical innovation and clinical research options. Atlantic Surgical Oncology Associates work closely with medical oncology, radiation oncology and other specialists in a multidisciplinary fashion on two campuses of the Carol G. Simon Cancer Center at Morristown Medical Center and Overlook Medical Center in Summit. Dr. Bickenbach is a member of a variety of medical organizations including the American College of Surgeons, the Society of Surgical Oncology, the American Society of Clinical Oncology, and the Americas Hepato-Pancreatico-Biliary Association, and is a councilman for the New Jersey Chapter of the American College of Surgeons. He is widely published and has presented at national meetings on cancer related topics.After graduating from Wayne State University School of Medicine in 2002, Dr. Bickenbach completed his surgical residency at the University of Chicago Medical Center in 2009, where he was elected administrative chief resident. During that time, Dr. Bickenbach completed a two-year research fellowship, focusing on the use of oncolytic viruses in the treatment of cancer. Following residency, Dr. Bickenbach completed a fellowship in Surgical Oncology at Memorial Sloan-Kettering Cancer Center. He sees patients at Morristown, Overlook, Newton, Chilton and Hackettstown medical centers. He is affiliated with Atlantic Medical Group, and is a participating provider of Atlantic Accountable Care Organization. Dr. Bickenbach is rated as an Experienced provider by MediFind in the treatment of Pseudomyxoma Peritonei. His top areas of expertise are Familial Colorectal Cancer, Colorectal Cancer, Familial Pancreatic Cancer, Small Bowel Resection, and Pancreatectomy.

Since 1999, Dr. Daniel Tobias has been a gynecologic oncologist at Atlantic Health System’s Women’s Cancer Center, diagnosing and treating conditions of the female reproductive system. He is dual board-certified in obstetrics and gynecology and gynecologic oncology, and he is part of Atlantic Medical Group with privileges at both Morristown and Overlook medical centers. He is currently the director of gynecologic oncology for Atlantic Health System.Dr. Tobias attended the University of Missouri-Kansas City School of Medicine for an integrated six-year combined bachelors of arts and medical degree program. He performed his residency at Albert Einstein College of Medicine’s Montefiore Medical Center and his fellowship in gynecologic oncology at Mount Sinai School of Medicine in New York. During his fellowship, Dr. Tobias served as principal investigator of a study initiated by the New York Gynecologic Oncology Group. Keenly interested in research, Dr. Tobias continues to bring clinical trials and research to his patients.As part of an integrated care team, Dr. Tobias treats gynecologic malignancies using a combination of modalities and advanced technologies to spare healthy tissue. His medical career includes many honors, awards, presentations and authored works.Dr. Tobias is affiliated with and involved in several professional societies including the Society of Gynecology Oncologists and the American College of Obstetricians and Gynecologists. He has extensive experience with radical surgery, intraperitoneal chemotherapy and laparoscopic surgery. Dr. Tobias has performed robotic surgery since 2005, helped develop a comprehensive gynecologic oncology robotics program, and trains other physicians to perform robotics surgery. He also participates in resident education. Dr. Tobias is rated as an Experienced provider by MediFind in the treatment of Pseudomyxoma Peritonei. His top areas of expertise are Endometrial Cancer, Endometrial Stromal Sarcoma, Malignant Mixed Mullerian Tumor, Hysterectomy, and Oophorectomy.

Dr. Sonyo Shin is an esteemed attending hematologist/oncologist at Advanced Care Oncology and Hematology Associates (ACOHA), a distinguished part of Atlantic Medical Group (AMG). With over 20 years of dedicated experience in the field, she is deeply committed to delivering patient-centered care in both hematology and oncology.Dr. Shin is board-certified in internal medicine, oncology, and hematology by the American Board of Internal Medicine. Her extensive expertise encompasses the treatment of a wide range of malignancies, including lymphoma, lung cancer, and chronic leukemia. She has been instrumental in developing and leading multidisciplinary breast cancer clinics, ensuring a comprehensive approach to patient care.In addition to her clinical practice, Dr. Shin is actively involved in clinical trials, contributing to the advancement of cancer research. She is also passionate about education, mentoring medical residents and students to foster the next generation of healthcare professionals. Her commitment to excellence in patient care and education underscores her role as a leader in the field of hematology and oncology. Dr. Shin is rated as an Advanced provider by MediFind in the treatment of Pseudomyxoma Peritonei. Her top areas of expertise are Paget Disease of the Breast, Familial Colorectal Cancer, Small Cell Lung Cancer (SCLC), and Lung Adenocarcinoma.

Jason Knight is a Gynecologic Oncologist and an Oncologist in Morristown, New Jersey. Dr. Knight is rated as an Experienced provider by MediFind in the treatment of Pseudomyxoma Peritonei. His top areas of expertise are Endometrial Cancer, Malignant Mixed Mullerian Tumor, Endometrial Stromal Sarcoma, Oophorectomy, and Hysterectomy. Dr. Knight is currently accepting new patients.

Sirish Dharmapuri is an Oncologist in Livingston, New Jersey. Dr. Dharmapuri is rated as an Experienced provider by MediFind in the treatment of Pseudomyxoma Peritonei. His top areas of expertise are Anal Cancer, Familial Colorectal Cancer, Colorectal Cancer, and Lynch Syndrome. Dr. Dharmapuri is currently accepting new patients.

Anna Litvak is an Oncologist in Livingston, New Jersey. Dr. Litvak is rated as an Experienced provider by MediFind in the treatment of Pseudomyxoma Peritonei. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Angiosarcoma, and Inflammatory Breast Cancer. Dr. Litvak is currently accepting new patients.

Stuart Leitner is an Oncologist in Livingston, New Jersey. Dr. Leitner is rated as an Experienced provider by MediFind in the treatment of Pseudomyxoma Peritonei. His top areas of expertise are Paget Disease of the Breast, Breast Cancer, Angiosarcoma, and Inflammatory Breast Cancer. Dr. Leitner is currently accepting new patients.

Russell Langan is a Surgical Oncologist in Livingston, New Jersey. Dr. Langan is rated as an Experienced provider by MediFind in the treatment of Pseudomyxoma Peritonei. His top areas of expertise are Pancreatic Cancer, Familial Pancreatic Cancer, Retroperitoneal Liposarcoma, Pancreaticoduodenectomy, and Pancreatectomy. Dr. Langan is currently accepting new patients.